PTH-034 Stress-induced immunomodulation in irritable bowel syndrome suppresses Th1 and Th2 cytokines

Dominic Bullas(St Mark's Hospital), Anthony Hobson(London Clinic), Salma Gurmany(St Mark's Hospital), Wendy Atkin(NIHR Research Delivery Network), Kirsty Hicks(GlaxoSmithKline (United Kingdom)), David C. Bulmer(Queen Mary University of London), Michael A. Kamm(The University of Melbourne), Naila Arebi, Laurens Kruidenier(GlaxoSmithKline (United Kingdom)), George E. Dukes
Unknown
April 1, 2010
Cited by 0


Related Papers